Entero Healthcare IPO closing soon: Check GMP and subscription details

Entero Healthcare Solutions Limited's IPO, which opened for subscription on Friday, is set to close on February 13, 2024.

The company aims to raise a hefty sum of Rs 1,600 crore through this initial public offering, with a huge portion of Rs 1,000 crore intended through the issuance of fresh shares.

As of today, the IPO has garnered a subscription of 0.19 times, with varying levels of interest across different investor categories.

The retail category has shown relatively higher interest, subscribing 0.63 times, while the Qualified Institutional Buyers (QIB) segment hasn't shown any subscription so far. Non-Institutional Investors (NII) have subscribed 0.10 times.

The Grey Market Premium (GMP) for Entero Healthcare Solutions IPO stands at Rs 10 as of February 13th, 2024. Considering the price band of Rs 1,258, the estimated listing price is projected to be Rs 1,268, reflecting a potential gain of 0.79 per cent per share.

Key details about the Entero Healthcare Solutions IPO:

The IPO is open until February 13, 2024, and the price band for subscription ranges from Rs 1,195 to Rs 1,258 per equity share.

The lot size comprises 11 company shares, and share allocation is expected to be finalized on February 14, 2024.

Link Intime India Private Limited serves as the registrar for the IPO, and the proposed listing is on both BSE and NSE.

As per the T+3 listing rule, the anticipated listing date is February 16, 2024.

Should you apply?

Ventura Securities and BP Equities have both recommended subscribing to the IPO. Ventura Securities highlights Entero Healthcare Solutions' notable growth and extensive reach in India's healthcare distribution sector, citing it as a reason for subscription.

Similarly, BP Equities sees value in the IPO's valuation and growth potential compared to its peers, hence suggesting a 'subscribe' rating.

(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)